2017
DOI: 10.1186/s13046-017-0528-y
|View full text |Cite
|
Sign up to set email alerts
|

Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells

Abstract: BackgroundCisplatin-based chemotherapy is frequently used to treat advanced gastric cancer (GC). However, the resistance often occurs with the mechanisms being not well understood. Recently, emerging evidence indicates that tumor-associated macrophages (TAMs) play an important role in chemoresistance of cancer. As the important mediators in intercellular communications, exosomes secreted by host cells mediate the exchange of genetic materials and proteins to be involved in tumor aggressiveness. The aim of the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
372
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 456 publications
(383 citation statements)
references
References 38 publications
11
372
0
Order By: Relevance
“…49 Crosstalk between TAM and cancer cells is complex and involves exosomes, cytokines, and metabolites. [50][51][52] In the present study, we focused on the cytokine CCL2 secreted by macrophages and TA B L E 1 Univariate and multivariate analyses of clinicopathological features associated with PFS of patients with hormone receptor-positive breast cancer examined its role in the endocrine resistance of breast cancer cells. We found that CCL2 activates the PI3K/Akt/mTOR pathway, which is a classical endocrine resistance pathway.…”
Section: Discussionmentioning
confidence: 99%
“…49 Crosstalk between TAM and cancer cells is complex and involves exosomes, cytokines, and metabolites. [50][51][52] In the present study, we focused on the cytokine CCL2 secreted by macrophages and TA B L E 1 Univariate and multivariate analyses of clinicopathological features associated with PFS of patients with hormone receptor-positive breast cancer examined its role in the endocrine resistance of breast cancer cells. We found that CCL2 activates the PI3K/Akt/mTOR pathway, which is a classical endocrine resistance pathway.…”
Section: Discussionmentioning
confidence: 99%
“…Whereas much of the focus of the field has been on the secretion of soluble factors, there has been recent evidence that the secretion of exosomes could be another mechanism used by TAMs to induce therapeutic resistance in tumor cells. For instance, exosomal miR‐21 secreted by TAMs confers cisplatin resistance in gastric cancer cells by enhancing the activation of PI3K/AKT signaling pathway . Similarly, another study has shown that the exosomal miR‐155 transferred by TAMs to neuroblastoma tumor cells induces resistance to cisplatin by directly down‐regulating TERF1, a component of the shelterin complex and inhibitor of telomerase …”
Section: Tumor‐associated Macrophages In Response To Chemotherapymentioning
confidence: 99%
“…Presumably, it is believed that such change is to promote survival, proliferation, and drug resistance of cancer cells, in part as a result of increased expression of chemoresistance‐inducing factor, Snail . Moreover, exosomes from TAM diminish chemotherapy sensitivity of cancers as a result of miR‐21 activity . These studies suggested that exosomes derived from tumor microenvironments play an active and essential role in the regulation of cancer chemo‐ and/or radiation resistance.…”
Section: Exosomes In Cancer Malignancymentioning
confidence: 99%